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a  b  s  t  r  a  c  t
There  is  an  important  need  to develop  alternative  anti-schistosomal  drugs,  as current  treat-
ment depends  mainly  on  praziquantel  (PZQ).  This work  aimed  to study  the  in  vivo  effect
of  meﬂoquine  on  worm  burden  and  tegumental  changes  on  both  the  juvenile  and  adult
worms in  experimental  Schistosoma  mansoni  infection.
We studied  the  effect  of  this  compound  in mice  infected  with  cercaria  of Schistosoma
manson  then  treated  with  a single  oral  dose  of  400  mg/kg  meﬂoquine,  3  and  7 weeks  after
infection  and  worms  were  recovered  two,  three  and  seven  days  following  treatment.  Worm
burden was  calculated  and  alterations  on  the  tegumental  surface  of schistosomula  were
examined  by electron  microscopy.  The  total  worm  burden  reduction  in  juvenile  was  94.5%
and in  adults  was 74.8%.  The  electron  microscopy  examination  showed  tegumental  changes
in the  form  of  retracted  ventral  sucker  and  oral  sucker,  fusion  of  tegumental  ridges,  pitting
of the  tegument  and  corrugations  with  swelling  of  the  tegument  in  parts  and shrinkage
in  the  other  parts  with  formation  of  deep  furrows,  disruption  and peeling  of  the  tegu-
ment  with  loss  of  spines  and  blebbing.  Meﬂoquine  has a promising  effect  in treatment  of
schistosomiasis.
© 2014  Saudi  Society  of  Microscopes.  Published  by  Elsevier  Ltd.  All  rights  reserved.. Introduction
Schistosomiasis is a chronic disease that exacerbates
overty [1]. About 800 million individuals are at risk and
ver  230 million people are thought to be infected [2,3].
In  schistosomiasis, there is no vaccine available yet and
he  current mainstay of control is chemotherapy. Praz-
quantel (PZQ) is the drug of choice for the treatment
f schistosomiasis because of its safety, broad-spectrum
ctivity, and reasonable cost [4].
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anti  malarial drug also as anti schistosomal drug, reduces
the  burden of schistosomiasis [5]. The antimalarials
artemether and meﬂoquine have promising antischistoso-
mal  properties [6].
2.  Materials and methods
2.1.  ParasitesCercariae of Schistosoma mansoni were obtained from
infected Biomphalaria alexandrina snails, which were
reared and maintained at Schistosome Biological Supply
Program (SBSP), Theodor Bilharz Research Institute, Giza,
ghts reserved.
roscopy8 A.F. Fakahany et al. / Journal of Mic
Egypt. This strain of S. mansoni was obtained originally
from Lowell University, Lowell, Massachusetts, U.S.A., and
has  been passed through out bred mice and B. alexandrina
snails.
2.2. Experimental animals
This  study was conducted on laboratory albino mice
strain CD1, clean from parasitic infection were used. They
were  all males (to spare any possible effect of pregnancy
hormones in females on the immune system of the mice)
weighting 20–25 g at the beginning of the experiment
and had similar age (3–5 weeks). Animals were fed on a
standard diet composed of about 24% proteins, 4% fat and
about  4.5% ﬁber.
2.3.  Experimental design
Mice  were infected subcutaneously with 80 ± 10 S. man-
soni  cercariae then meﬂoquine was given at 21 and 49 days
post  infection. Mice were grouped into:
Group  I: Treated with single oral dose of meﬂoquine
(400 mg/kg) at 21 days post infection to study the effect of
meﬂoquine on juvenile stage of S. mansoni.
Group II: Treated with single oral dose of meﬂoquine
(400 mg/kg) at 49 days post infection to study the effect of
meﬂoquine on adult stage of S. mansoni.
Group III: Control group of infected untreated mice at 21
days.
Group IV: Control group of infected untreated mice at 49
days.
Each group contains 20 mice which were sacriﬁced by
decapitation [7] at different intervals two days, three days
and one week post treatment to count the worms and
detect the tegumental changes at these intervals.
Group V: Uninfected and untreated (healthy control
group).
2.4. Drug preparation and adjustment of the dose
Meﬂoquine drug (Mepha Ltd., Aesch-Basel,
Switzerland), each Lactab contains: meﬂoquine base
250  mg  (in the form of 275 mg  meﬂoquine hydrochloride).
The dose was 400 mg/kg [8].
The drug supplied as powder is suspended in 7% Tween,
80.3% absolute alcohol and distilled water shortly before
use  in dose 400 mg/kg orally once.
In case of mice harboring adult S. mansoni worms (49
days  post infection) the mice were weighting 24–25 g each,
while  in case of mice harboring juvenile S. mansoni worms
(21  days post infection) the mice were weighting 19–21 g
each.
2.5.  Recovery of parasitesRecovery  of juvenile and adult schistosome worms was
achieved by Porto-mesenteric perfusion of livers of S. man-
soni  infected mice. and Ultrastructure 2 (2014) 7–11
The  collected worms were then counted under a stereo-
microscope [9].
2.6.  Scanning electron microscopy (SEM) examination
Scanning electron microscopy examination was per-
formed according to Hassan et al. [10], to determine the
extent  of damage on the surface of treated worms in com-
parison  to the untreated worms.
2.6.1. Preparation of worms: [10]
Adult male worms of S. mansoni perfused from the
hepatic and portomesentric vessels of infected mice were
collected in glutaraldehyde buffer solution (25%) as a ﬁxa-
tive  over night at 4 ◦C, then washed out of any of the ﬁxative
by  keeping them over night at 4 ◦C in phosphate buffer then
passed  into rising concentrations of alcohol (30%, 40%, 50%)
each  for 15 min  and kept in 70% alcohol until the time of
examination.
Before  examination, they were washed twice for 30 min
in  80% and 90% alcohol respectively. The last wash was  for
one  hour in 100% alcohol.
Worms  were then mounted on stainless steel holders
and put in a drier for about 30 min  and then subjected
to sputter coat of gold, the different parts of worms were
examined using Joel JEM-1200 scanning electron micro-
scope, provided with a camera ﬁtted to it. Areas in the
worms  that showed speciﬁc changes were examined and
photographed mainly, suckers and the tubercles on the
tegument.
2.7.  Statistical analysis
The  collected data will be tabulated and analyzed using
IBM  personal computer using SPSS 16 microstate soft ware
package.
ANOVA  (analysis of variance) “f” test was used as the
test of signiﬁcance. P value was  considered signiﬁcant if it
was  <0.05.
Bonferroni test was  used as the multiple comparison
tests after obtaining signiﬁcant result by “f” test i.e. post
hoc  comparison to determine which pair was  signiﬁcantly
different [11].
3.  Results and discussion
The  results are shown in Table 1 and Figs. 1–12.
Treatment of schistosomiasis relies almost exclusively
on praziquantel. However, drug resistance is a real threat,
particularly in the light of large-scale administration of
praziquantel [12]. Praziquantel shows also a deﬁciency in
its  spectrum of activity, it has moderate activity against
juvenile worms so there is a need for the development of
new  drugs for the treatment of schistosomiasis [13].
Reduction in worm burden is an important parameter
for assessment of anti schistosomal activity of drugs in lab-
oratory  animals [14].
The  rule served by the tegument in the immune evasion
and parasite homeostasis was studied by Otubanjo et al.
[15].  They revealed the importance of the tegument as a
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Table 1
Effect of a single 400 mg/kg oral dose of meﬂoquine administered to mice harboring a 49-day-old adult S. mansoni infection on worm burden.
N mice X′ ± SD % of total worm burden
reduction
Post  hoc and p value
Juveniles Adults Juveniles Adults Juveniles Adults
Control 20 20 15.2 ± 1.8 15.8 ± 1.1
2  days post treatment 6 6 3.7 ± 0.8 8.7 ± 2.6 75.9 44.9 • Control group and
perfused group 2 days
post  treatment <0.001
3  days post treatment 5 5 2.8 ± 1.9 6.6 ± 1.8 81.6 58.2 • Control group and
perfused group 3 days
post  treatment <0.001
7  days post treatment 6 4 0.7 ± 0.5 4.3 ± 1.5 95.8 72.8 • Control group and
perfused group 7 days
post  treatment <0.001
•  Perfused group 2 days






















bNOVA = 101.1, P < 0.001.
arget for antischistosomal drugs. Each drug induces char-
cteristic changes in the tegument. The ultrastructure of
he  worm after drug administration clarify the procedure
f  killing of these worms [10].
In the present work, we studied the effect of meﬂoquine
n the worm burden and tegument of juvenile and adult S.
ansoni  worms by scanning electron microscopy.
Concerning the effect of meﬂoquine on the total worm
urden, we found that meﬂoquine has a great effect both
n  juvenile and adult worms reaches maximum (95.8%
nd  72.8% reduction respectively) 7 days after treatment.
hese results are in parallel with that reported by Keiser
t  al. [8] who reported that in juvenile infection (21-day-
ost infection), total worm burden reduction of 97.2%, and
otal  worm burden reduction in mature infection 77.3% was
bserved  with a single oral dose of meﬂoquine (400 mg/kg),
eiser  et al. [16] also reported that the total worm bur-
en  reduction in juvenile infection of 97.8% and in mature
nfection of 77.8% was observed with a single oral dose of
eﬂoquine (200 mg/kg) was achieved with a single-dose























Juvenile worms adut  worms
ig. 1. Effect of a single 400 mg/kg oral dose of meﬂoquine on mean num-
er of worms.days  post
treatment = 0.001
On the other hand Van Nassauw et al. [17] reported
that, meﬂoquine at 150 mg/kg had no effect on worm
burden, but signiﬁcantly reduced the number of eggs in
the  ﬁrst three developmental egg stages and concluded
that, meﬂoquine signiﬁcantly reduces egg production in
S.  mansoni-infected mice. This controversy regarding the
effective  dose needs more studies.
Basra et al. [18] used meﬂoquine as intermittent preven-
tive  treatment against malaria in pregnancy in a clinical
trial  in Gabon, it showed promising activity against con-
comitant Schistosoma haematobium infection leading to an
important  reduction of egg excretion in pregnant women.
Concerning the tegumental changes, we found that
schistsomules and adult worms  recovered from treated
mice showed a variable degree of tegumental changes in
the  form of retracted ventral sucker and oral sucker, fusion
of  tegumental ridges, pitting, deep furrows, disruption and
peeling  of the tegument with loss of spines and blebbing.
Also corrugations with swelling of the tegument in parts
and  shrinkage in the other parts with formation of vesicles
and  deep furrows. These changes were more prominent in
female  worms.
Blebbing is an indicator for stress and has been observed
in  previous studies evaluating anti-schistosomal drugs by
scanning  electron microscopy [19].
These results are in parallel with that reported by Pica-
Mattoccia and Cioli [20]. They reported that following
in vitro exposure to meﬂoquine, the tegument of female
worms was slightly more affected and died more rapidly
when compared to male worms.
These results are also similar to that, reported by Man-
nack et al. [21] They reported that a single oral dose of
meﬂoquine (400 mg/kg) to S. mansoni-infected mice caused
localized  blebbing on the tegument appeared after one day
and  became more sever three days after treatment partic-
ularly  in female worms. Moreover they found that the oral
suckers  were shrunken with deep furrows, their inner sur-
face  was  covered by small spines while the outer margin
were  not affected. Moreover Mannack [22] revealed by SEM
blebbing,  shrinking and sloughing on the tegument of adult
S.  mansoni worms  following meﬂoquine administration in
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Figs. 2–12. Explanation of scanning electron micrograph (SEM) of S. mansoni ﬁgures: (2) Schistosomule two  days post treatment showing retracted ventral
sucker  and fusion of tegumental ridges (2000×). (3) Schistosomule three days post treatment showing pitting of the tegument (5000×). (4) Schistosomule
seven  days after treatment showing furrows on the tegument (2400×). (5) Schistosomule seven days post treatment showing retracted oral sucker (6000×).
(6)  Male after 2 days with meﬂoquine treatment showing disruption and peeling of the tegument with loss of spines and ﬂattening of the ventral sucker
(vs)  (600×). (7) Male after 2 days with meﬂoquine treatment showing deformity of the oral sucker (os) (1000×). (8) Female after 2 days post meﬂoquine
treatment showing shedding of the tegument from the basement membrane (1200×). (9) Female two  days post meﬂoquine treatment showing disruption
uine tre
ent wiand  peeling of the tegument (1600×). (10) Male after 3 days post meﬂoq
Female  after 3 days with meﬂoquine treatment showing shrunken tegum
treatment  showing ﬂat tegument with ﬂat ventral sucker (1000×).
mice and concluded that meﬂoquine possesses excellent
antischistosomal properties.
In related experiments but on Schistosoma japoicum
Zhang and Xiao [23] studied the effect of 200 mg/kg meﬂo-
quine  on 14 days old S. japonicum in mice and reported
tegumental changes in the form of swelling and peeling and
stated  that it exhibits a potential and fast killing effect and
induces  sever histopathological lesions. In another study
on  juvenile S. japonicum. Xiao et al. [24] studied the ultraatment showing shrunken oral sucker with deep furrows (2031×). (11)
th formation of deep furrows (112×). (12) Male 7 days after meﬂoquine
structural alteration induced by 400 mg/kg meﬂoquine in
mice  and found tegumental alteration characterized by
emergence of irregular and elongated cytoplasmic pro-
cesses  and concluded that meﬂoquine causes extensive
ultrastructural damage to juvenile S. japonicum.So it is clear that meﬂoquine has two advantages over
praziquantel ﬁrst it showed a signiﬁcant effect on the worm
burden  and tegument of both juvenile stages and adults of
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n juvenile schistosomula as indicated by Doenhoff et al.
13].  Second advantage is that malaria and schistosomia-
is coexist in large areas in tropical and subtropical Africa
nd  meﬂoquine can treat both infections. We  conclude that
oth  calculating the worm burden and SEM of tegumen-
al  changes are effective in follow up treatment in mice
nfected with S. mansoni and that meﬂoquine had advan-
ages  over praziquantel and may  take place in future for
reatment of schistosomiasis.
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